Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Should be interesting

<< Previous

Bullboard Posts

Next >>

Comment by mdjbrownon Aug 24, 2023 5:08pm

111 Views

Post# 35604426

RE:RE:RE:RE:RE:Should be interesting

Not sure who they are s1i, but they are sure targettng recognisable comparables with their approved cbd products in Brazil

Epidiolex, Sativex - nabiximols, and dronabinol

Looks like they have been trying for a few years to raise capital, so I am not sure who is paying for clinical testing of all of their formulas to ensure they are safe and effective.

With 8 approved ANVISA CBD related drugs in Brazil in a relatively short time, it might be a bit of a wild west show over there for a while.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security